| Literature DB >> 35246692 |
Akshay Kriplani1, Shruti Pandit1, Arun Chawla2, Jean J M C H de la Rosette3, Pilar Laguna3, Suraj Jayadeva Reddy1, Bhaskar K Somani4.
Abstract
The objective of this prospective observational study was to assess the clinical significance of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) as potential biomarkers to identify post-PNL SIRS or sepsis. Demographic data and laboratory data including hemoglobin (Hb), total leucocyte count (TLC), serum creatinine, urine microscopy and culture were collected. The NLR, LMR and PLR were calculated by the mathematical division of their absolute values derived from routine complete blood counts from peripheral blood samples. Stone factors were assessed by non-contrast computerized tomography of kidneys, ureter and bladder (NCCT KUB) and included stone burden (Volume = L × W × D × π × 0.167), location and Hounsfield value and laterality. Intraoperative factors assessed were puncture site, tract size, tract number, operative time, the need for blood transfusion and stone clearance. Of 517 patients evaluated, 56 (10.8%) developed SIRS and 8 (1.5%) developed sepsis. Patients developing SIRS had significantly higher TLC (10.4 ± 3.5 vs 8.6 ± 2.6, OR 1.19, 95% CI 1.09-1.3, p = 0.000002), higher NLR (3.6 ± 2.4 vs 2.5 ± 1.04, OR 1.3, 95% CI = 1.09-1.5, p = 0.0000001), higher PLR (129.3 ± 53.8 vs 115.4 ± 68.9, OR 1.005, 95% CI 1.001-1.008, p = 0.005) and lower LMR (2.5 ± 1.7 vs 3.2 ± 1.8, OR 1.18, 95% CI 1.04-1.34, p = 0.006). Staghorn stones (12.8 vs 3.24%, OR 4.361, 95% CI 1.605-11.846, p = 0.008) and long operative times (59.6 ± 14.01 vs 55.2 ± 16.02, OR 1.01, 95% CI 1.00-1.03, p = 0.05) had significant association with postoperative SIRS. In conclusion, NLR, PLR and LMR can be useful independent, easily accessible and cost-effective predictors for early identification of post-PNL SIRS/sepsis.Entities:
Keywords: Endourology; PCNL; Renal stones; SIRS; Sepsis
Mesh:
Year: 2022 PMID: 35246692 PMCID: PMC9110452 DOI: 10.1007/s00240-022-01319-0
Source DB: PubMed Journal: Urolithiasis ISSN: 2194-7228 Impact factor: 2.861
Patient characteristics, preoperative laboratory values and stone characteristics
| Variables | All patients | SIRS ( ± ) | SIRS (+) | Sepsis (−) | Sepsis (+) | ||
|---|---|---|---|---|---|---|---|
| Patient characteristics | |||||||
| Age (years) (mean ± SD) | 48.13 ± 13.92 | 47.5 ± 13.8 | 46.5 ± 14.5 | 0.6 | 47.4 ± 13.9 | 45 ± 13.3 | 0.6 |
| Gender | |||||||
| Female | 127 (24.6%) | 112 (88.2%) | 15 (11.8%) | 0.68 | 126 (99.2%) | 1 (0.8%) | 0.42 |
| Male | 390 (75.4%) | 349 (89.5%) | 41 (10.5%) | 383 (98.2%) | 7 (1.8%) | ||
| BMI (kg/m2) | 25.23 ± 2.94 | 25.2 ± 2.93 | 25.3 ± 2.9 | 0.7 | 25.1 ± 2.9 | 27.3 ± 1.9 | 0.03* |
| Hypertension | 145 (27.9%) | 120 (26%) | 14 (25%) | 1.0 | 132 (26%) | 2 (25%) | 1.0 |
| Diabetes mellitus | 96 (18.5%) | 82 (17.8%) | 12 (21.4%) | 0.4 | 90 (17.7%) | 4 (50%) | 0.04 |
| History of previous ipsilateral PCNL (%) | 23 (4.4%) | 19 (4.1%) | 4 (7.1%) | 0.3 | 23 (4.5%) | 0 | 1.0 |
| Preoperative laboratory values | |||||||
| Hemoglobin (gm/dl) | 13.29 ± 1.91 | 13.4 ± 1.8 | 12.8 ± 2.3 | 0.04* | 13.3 ± 1.9 | 12.9 ± 2.5 | 0.6 |
| TLC (/mm3) | 8.73 ± 3.84 | 8.6 ± 2.6 | 10.4 ± 3.5 | 0.000002* | 8.8 ± 2.8 | 9.5 ± 2.3 | 0.4 |
| Creatinine (mg/dl) | 1.42 ± 4.30 | 1.4 ± 4.5 | 1.2 ± 0.7 | 0.75 | 1.4 ± 4.3 | 1.03 ± 0.3 | 0.8 |
| NLR | 2.6 ± 2.1 | 2.5 ± 1.04 | 3.6 ± 2.4 | 0.0000001* | 2.6 ± 2.1 | 3.9 ± 5.7 | 0.2 |
| PLR | 118.3 ± 69.5 | 115.4 ± 68.9 | 129.3 ± 53.8 | 0.005* | 118.2 ± 69.7 | 143.2 ± 70.03 | 0.6 |
| LMR | 2.6 ± 1.7 | 3.2 ± 1.8 | 2.6 ± 1.7 | 0.006* | 4.07 ± 2.8 | 2.5 ± 1.7 | 0.02* |
| Stone characteristics | |||||||
Stone volume (mm3) [median (Q1-Q3)] | 880.95 (524.38–1801.25) | 825 (503–1573) | 890 (529–3089) | 0.3 | 839 (515–1641) | 849 (616–1090) | 0.9 |
| Hounsfield unit (HU) | 970.59 ± 278.55 | 986 ± 253.1 | 1017 ± 294.4 | 0.39 | 753 ± 407 | 993 ± 253 | 0.009* |
| Staghorn (%) | 4.06 | 3.24 | 12.8 | 0.008* | 4.12 | 0 | 1.0 |
Stone location (%) | |||||||
| Simple | 87.8 | 88.1 | 85.7 | 0.6 | 87.6 | 100 | 0.6 |
| Complex | 12.2 | 11.9 | 14.3 | 12.4 | 0 | ||
| Intraoperative characteristics | |||||||
| Puncture site (%) | |||||||
| Supracostal ( | 14.7 | 13.9 | 19.6 | 0.2 | 14.5 | 12.5 | 1.0 |
| Infracostal ( | 85.3 | 86.1 | 80.4 | 85.5 | 87.5 | ||
| Tract size [median (Q1-Q3)] | 28 (26–32) | 28 (26–32) | 28 (26–32) | 0.2 | 28 (26–32) | 28 (15–32) | 0.8 |
| Bilateral puncture (%) | 4.6 | 4.3 | 7.1 | 0.3 | 4.6 | 0 | 1.0 |
| Tract number (%) | |||||||
| Single puncture | 97.6 | 97.4 | 100 | 0.3 | 97.6 | 100 | 1.0 |
| > 1 puncture | 2.35 | 2.6 | 0 | 2.4 | 0 | ||
| Blood transfusion (%) | 2.9 | 2.6 | 7.1 | 0.08 | 2.9 | 12.5 | 0.2 |
| Operative time (minutes) | 55.99 ± 16.71 | 55.2 ± 16.02 | 59.6 ± 14.01 | 0.05* | 55.7 ± 15.8 | 55 ± 17.3 | 0.8 |
| LOH (days) | 2.34 ± 1.78 | 2.22 ± 1.75 | 3.30 ± 1.71 | 0.00003* | 2.34 ± 1.78 | 3.34 ± 1.69 | 0.001* |
*Values are statistically significant
Univariate and multivariate logistic regression analyses for predictors of post-PCNL SIRS
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Unadjusted OR | Adjusted OR | |||
| Patient characteristics | ||||
| Age | 0.9 (0.97–1.01) | 0.61 | 1.007 (0.96–1.04) | 0.7 |
| Gender | ||||
| Female | 0.87 (0.46–1.6) | 0.68 | 1.48 (0.39–5.6) | 0.57 |
| Male | 1.0 | 1.0 | ||
| BMI | 1.01 (0.92–1.11) | 0.75 | 1.10 (0.92–1.31) | 0.28 |
| Hypertension | ||||
| Yes | 0.94 (0.5–1.7) | 0.86 | 1.03 (0.27–3.9) | 0.95 |
| No | 1.0 | |||
| Diabetes mellitus | ||||
| Yes | 1.2 (0.63–2.49) | 0.5 | 0.29 (0.65–1.3) | 0.1 |
| No | 1.0 | |||
| History of previous PCNL | 1.7 (0.58–5.46) | 0.3 | 1.0 (0.36–1.56) | 0.01* |
| Preoperative laboratory values | ||||
| Hemoglobin | 0.86 (0.7–0.9) | 0.04* | 0.74 (0.53–1.03) | 0.07 |
| TLC | 1.19 (1.09–1.3) | 0.00006* | 1.22 (1.04–1.42) | 0.01* |
| Creatinine | 0.98 (0.85–1.12) | 0.77 | 0.72 (0.17–2.96) | 0.65 |
| Preoperative pyuria | 1.0 | 0.151 | 0.99 (0.99–1.002) | 0.65 |
| NLR | 1.3 (1.09–1.5) | 0.003* | 1.65 (1.22–2.24) | 0.001* |
| PLR | 1.005 (1.001–1.008) | 0.006* | 1.008 (1.002–1.014) | 0.008* |
| LMR | 1.18 (1.04–1.34) | 0.008* | 1.27 (1.03–1.56) | 0.025* |
| Stone characteristics | ||||
| Stone volume | 1.0 | 0.8 | 1.0 | 0.84 |
| Hounsfield unit (HU) | 1.0 (0.99–1.002) | 0.3 | 1.0 | 0.07 |
| Staghorn | 4.361 (1.605–11.846) | 0.004* | 0.594 (0.032–10.944) | 0.726 |
| Stone location ( | ||||
| Simple | 0.478 (0.394–1.548) | 0.61 | 1.582 (0.205–12.207) | 0.660 |
| Complex | ||||
| Puncture site | ||||
| Supracostal ( | 0.6 (0.32–1.34) | 0.25 | 0.52 (1.38–1.95) | 0.33 |
| Infracostal | ||||
| Tract size | 0.97 (0.92–1.02) | 0.25 | 0.88 (0.69–1.12) | 0.31 |
| Bilateral puncture | 1.6 (0.5–5.1) | 0.3 | ||
| Simultaneous Ipsilateral URS( | 1.27 (0.28–5.8) | 0.7 | 1.62 (0.10–24.8) | 0.72 |
| PNL type | ||||
| Standard | 0.697 (0.31–1.56) | 0.38 | 0.720 (0.024–21.4) | 0.85 |
| Mini PNL | ||||
| Tubeless | ||||
| Operative time | 1.01 (1.00–1.03) | 0.05* | 1.02 (0.98–1.06) | 0.25 |
| LOH | 1.31 (1.15–1.49) | 0.00004* | 1.46 (1.16–1.83) | 0.001* |
*Values are statistically significant
Fig. 1Receiver operating characteristic (ROC) curve analysis results of NLR, PLR and LMR in predicting postoperative SIRS
Fig. 2Receiver operating characteristic (ROC) curve analysis results of NLR, PLR and LMR in predicting postoperative sepsis